Multani Pratik S's Form 4 filing
Oric Pharmaceuticals, Inc. (ORIC) · filed Dec 16, 2022
- Accession no.
- 0001209191-22-061756
- Filed
- Dec 16, 2022
- Trade date
- Dec 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.79K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001209191-23-010616 (Feb 17, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Multani Pratik SCIK 0001586894 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Common Stock | MOption exerciseAcquired | +6,041 | $0.00F1 | $0 | 9,512 | Direct | |
| Dec 15, 2022 | Common Stock | SSaleDisposed | −2,089 | $3.25 | −$6,789.25 | 7,423 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Common Stock | MOption exerciseDisposed | −6,041 | $0.00 | $0 | 12,084 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock.
Referenced by the price of 1 transaction in Table I.